Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Current Assets (2020 - 2025)

Historic Current Assets for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $388.5 million.

  • Cytek Biosciences' Current Assets fell 43.62% to $388.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $388.5 million, marking a year-over-year decrease of 43.62%. This contributed to the annual value of $396.4 million for FY2024, which is 111.87% up from last year.
  • As of Q3 2025, Cytek Biosciences' Current Assets stood at $388.5 million, which was down 43.62% from $382.8 million recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Current Assets registered a high of $454.0 million during Q4 2022, and its lowest value of $216.9 million during Q2 2021.
  • Over the past 5 years, Cytek Biosciences' median Current Assets value was $409.4 million (recorded in 2023), while the average stood at $402.5 million.
  • Per our database at Business Quant, Cytek Biosciences' Current Assets skyrocketed by 10694.51% in 2021 and then crashed by 1364.7% in 2023.
  • Over the past 5 years, Cytek Biosciences' Current Assets (Quarter) stood at $431.7 million in 2021, then increased by 5.16% to $454.0 million in 2022, then dropped by 13.65% to $392.1 million in 2023, then increased by 1.12% to $396.4 million in 2024, then fell by 2.01% to $388.5 million in 2025.
  • Its Current Assets was $388.5 million in Q3 2025, compared to $382.8 million in Q2 2025 and $380.5 million in Q1 2025.